S. 2305 · 118th Congress

Biosimilar Red Tape Elimination Act

Introduced on Jul 13, 2023 by Mike Lee (R-UT). 4 cosponsors, 1 of them from another party. Latest action (Jul 13, 2023): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Stage
Introduced
Introduced
Jul 13, 2023
Cosponsors
4
1 from the other party
Policy area
Health
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. 2Reported by committee
  3. 3Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

A bill to improve the requirements for making a determination of interchangeability of a biological product and its reference product.

Summary

The Congressional Research Service has not summarized this measure yet.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Mike LeeR-UTSponsor

Democrats · 1

Republicans · 3

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Jul 13, 2023Introduced in Senate
  2. Jul 13, 2023 · SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA11 reports
    $37.4M reported (all issues)
  2. BCBSM, Inc.7 reports
    $208.5K reported (all issues)
  3. BIOTECHNOLOGY INNOVATION ORGANIZATION6 reports
    $8.9M reported (all issues)
  4. Blue Cross and Blue Shield Association6 reports
    $9.5M reported (all issues)
  5. Blue Cross and Blue Shield of Florida, Inc.6 reports
    $980K reported (all issues)
  6. GUIDEWELL MUTUAL HOLDING CORPORATION6 reports
    $40K reported (all issues)
  7. AMGEN INC.5 reports
    $15.2M reported (all issues)Federal contractor: AMGEN INC.AI match · 99%
  8. ASSOCIATION FOR ACCESSIBLE MEDICINES5 reports
    $3M reported (all issues)
  9. CAMBIA HEALTH SOLUTIONS INC.5 reports
    $3.2M reported (all issues)
  10. Campaign for Sustainable Drug Pricing (CSRxP)5 reports
    $120K reported (all issues)
  11. ELEVANCE HEALTH, INC.5 reports
    $7.6M reported (all issues)
  12. GSK (fka GLAXOSMITHKLINE INC.)5 reports
    $6.3M reported (all issues)
  13. JOHNSON & JOHNSON SERVICES, INC.5 reports
    $8.9M reported (all issues)
  14. TEVA PHARMACEUTICALS USA, INC.5 reports
    $2.5M reported (all issues)Federal contractor: TEVA PHARMACEUTICALS USA, INC.$25.9M in contracts, FY2026AI match · 100%
  15. American Society of Health-System Pharmacists4 reports
    $920K reported (all issues)Federal contractor: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS INC$350.5K in contracts, FY2026AI match · 100%
  16. PRIME THERAPEUTICS LLC4 reports
    $390K reported (all issues)
  17. BLUE CROSS AND BLUE SHIELD OF KANSAS, INC.3 reports
    $25K reported (all issues)
  18. TAKEDA PHARMACEUTICALS AMERICA, INC.3 reports
    $2.4M reported (all issues)Federal contractor: TAKEDA PHARMACEUTICALS AMERICA, INC.$1.6M in contracts, FY2026AI match · 100%
  19. The Campaign for Sustainable Rx Pricing3 reports
    $180K reported (all issues)
  20. AMNEAL PHARMACEUTICALS INC.2 reports
    $440K reported (all issues)Federal contractor: AMNEAL PHARMACEUTICALS OF NEW YORK, LLC$467.7K in contracts, FY2026AI match · 98%
  21. Americans for Prosperity2 reports
    $900K reported (all issues)
  22. Government Counsel, LLC (obo) Prime Therapeutics2 reports
    $20K reported (all issues)
  23. Pharmaceutical Industry Labor-Management Association2 reports
    $60K reported (all issues)
  24. The Cigna Group and subsidiaries (Formerly Cigna Corporation2 reports
    $3.1M reported (all issues)
  25. AMERICAN ASSOCIATION OF NEUROLOGICAL SURGEONS1 report
    $35K reported (all issues)
  26. American Society for Dermatologic Surgery Association1 report
  27. Association of Accessible Medicines (formerly known as GPhA)1 report
    $60K reported (all issues)
  28. BLUE CROSS BLUE SHIELD OF MICHIGAN1 report
    $266K reported (all issues)
  29. Congress of Neurological Surgeons1 report
    $35K reported (all issues)
  30. Fresenius Kabi USA LLC1 report
    $340K reported (all issues)Federal contractor: FRESENIUS KABI USA, LLCAI match · 100%
  31. KAISER FOUNDATION HEALTH PLAN INC.1 report
    $220K reported (all issues)Federal contractor: KAISER FOUNDATION HEALTH PLAN OF WASHINGTONAI match · 97%
  32. NATIONAL COMMUNITY PHARMACISTS ASSOCIATION1 report
    $330K reported (all issues)Federal contractor: NATIONAL COMMUNITY PHARMACISTS ASSOCIATIONAI match · 100%
  33. NOVARTIS CORPORATION1 report
    $720K reported (all issues)Federal contractor: NOVARTIS PHARMACEUTICALS CORPORATION$36.2M in contracts, FY2026AI match · 100%
  34. North American Society for Pediatric Gastroenterology, Hepatology and Nutrition1 report
    $25.5K reported (all issues)
  35. PFIZER INC.1 report
    $2.5M reported (all issues)Federal contractor: PFIZER INCAI match · 100%
  36. VIZIENT, INC.1 report
    $780K reported (all issues)Federal contractor: VIZIENT INC$18.2K in contracts, FY2026AI match · 98%

Reports filed in 2023, 2024, 2025, 2026.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 10, 2026 · loaded Oct 10, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 10, 2026 · loaded Oct 10, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.